Tired of ads? Enjoy an ad-free experience by signing up.
👩‍🍳 How we use AI at Tech in Asia, thoughtfully and responsibly.
🧔‍♂️ A friendly human may check it before it goes live. More news here

Susquehanna Asia VC leads gut health startup’s $11.8m series B

Gut health startup The Good Bug has raised 100 crore rupee (US$11.8 million) in its series B funding round, led by Susquehanna Asia VC with participation from Fireside Ventures.

The funds will support research in gut microbiome science and help expand the company’s reach across India.

Investments will focus on R&D, marketing, distribution, and hiring for science and technology teams.

Founded in 2022 by Keshav Biyani and Prabhu Karthikeyan, The Good Bug offers gut health products aimed at addressing issues caused by poor dietary and lifestyle habits.

The company has raised a total of US$18.8 million to date, with over 1 million reported customers.

🔗 Source: Inc42


🧠 Food for thought

1️⃣ India’s gut health market is riding a post-pandemic wellness wave

The funding for The Good Bug reflects a broader trend in India’s wellness sector, where gut health startups collectively raised over ₹43 crore in FY24 alone 1.

This market surge is largely driven by post-pandemic consumer behavior shifts, with preventative healthcare becoming a priority and digestive wellness moving from purely medical concerns to mainstream wellness 1.

The global digestive health products market, valued at $51.62 billion, is projected to grow at an impressive 8.3% CAGR, indicating that The Good Bug’s expansion is well-timed to capitalize on increasing consumer interest 2.

The company’s focus on both digestive health and weight management directly addresses the two fastest-growing segments within the gut health market, potentially explaining their rapid growth to 1 million customers in just two years since founding 3.

With 60% of revenue coming from their own website, The Good Bug exemplifies the direct-to-consumer approach that’s reshaping how health supplements are marketed and sold in India.

2️⃣ Scientific validation becoming crucial differentiator in crowded wellness space

The Good Bug’s emphasis on research-backed products, including their metabolic program claiming clinical results of 12.01% weight reduction over 90 days, represents a critical shift in the industry 3.

Consumers increasingly demand evidence-based products, moving beyond marketing claims to seek supplements with demonstrated efficacy, particularly as social media has both increased awareness and skepticism 1.

Stay ahead in Asia’s tech landscape

You've reached your 2 free content limit for the month. Sign up for free to read the full story.

🏄 For casual readers / 👶 Free

Basic

US$0

Free forever

Get instant access to this article and more every month

0 premium content

Unlimited news briefs

5

5 articles

Ad-free reading experience

Just US$0 per day

⌛Sign up in 20s. No payment details needed.

📖 For learners / 👍 Starter

Lite

US$4.92/month

Billed annually at US$59/year

Get instant access to this article and more every month

4

4 premium content

Unlimited news briefs & articles

Ad-free reading experience

Just US$0.17 per day

Cancel anytime

Our subscriber community includes professionals from these companies:

Stay updated on the go with our mobile app.

Get latest insights with smoother, more personalized experience through TIA mobile app.